Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Dorr

Showing results (111-120 of 156) with videos related to

Pageof 16
Sort By:
Biopharmaceutics & Drug Disposition|July 1, 1994
A comparison of HPLC and bioassay methods for plasma melanotan-II (MT-II) determination: application to a pharmacokinetic study in ratsS O Ugwu, J Blanchard, L D Nguyen, et al.
Cancer|December 15, 1989
High levels of doxorubicin in the tissues of a patient experiencing extravasation during a 4-day infusionR T Dorr, M S Dordal, L M Koenig, et al.
Journal of Medicinal Chemistry|December 6, 1996
2-[2'-(Dimethylamino)ethyl]-1,2-dihydro- 3H-dibenz[de,h]isoquinoline-1,3-diones with substituents at positions 4, 8, 9, 10, and 11. Synthesis, antitumor activity, and quantitative structure-activity relationshipsS M Sami, R T Dorr, D S Alberts, et al.
Journal of Medicinal Chemistry|July 1, 1991
Structure-activity relationships for mitomycin C and mitomycin A analoguesK R Kunz, B S Iyengar, R T Dorr, et al.
Journal of Medicinal Chemistry|March 17, 1995
Amino-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H- dibenz[de,h]isoquinoline-1,3-diones. Synthesis, antitumor activity, and quantitative structure--activity relationshipS M Sami, R T Dorr, A M Sólyom, et al.
Cancer Treatment Reports|July 1, 1985
Methotrexate: bioavailability and pharmacokineticsM A Campbell, D G Perrier, R T Dorr, et al.
Journal of Medicinal Chemistry|August 24, 2000
Analogues of amonafide and azonafide with novel ring systemsS M Sami, R T Dorr, D S Alberts, et al.
Cancer Research|January 15, 1989
Antitumor activity and murine pharmacokinetics of parenteral acronycineR T Dorr, J D Liddil, D D Von Hoff, et al.
Bone Marrow Transplantation|April 15, 2003
Comparative pharmacokinetic study of high-dose etoposide and etoposide phosphate in patients with lymphoid malignancy receiving autologous stem cell transplantationR T Dorr, A Briggs, P Kintzel, et al.
Investigational New Drugs|January 1, 1996
Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitorR T Dorr, K Dvorakova, K Snead, et al.
Pageof 16

Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Biopharmaceutics & Drug Disposition|July 1, 1994
A comparison of HPLC and bioassay methods for plasma melanotan-II (MT-II) determination: application to a pharmacokinetic study in ratsS O Ugwu, J Blanchard, L D Nguyen, et al.
Cancer|December 15, 1989
High levels of doxorubicin in the tissues of a patient experiencing extravasation during a 4-day infusionR T Dorr, M S Dordal, L M Koenig, et al.
Journal of Medicinal Chemistry|December 6, 1996
2-[2'-(Dimethylamino)ethyl]-1,2-dihydro- 3H-dibenz[de,h]isoquinoline-1,3-diones with substituents at positions 4, 8, 9, 10, and 11. Synthesis, antitumor activity, and quantitative structure-activity relationshipsS M Sami, R T Dorr, D S Alberts, et al.
Journal of Medicinal Chemistry|July 1, 1991
Structure-activity relationships for mitomycin C and mitomycin A analoguesK R Kunz, B S Iyengar, R T Dorr, et al.
Journal of Medicinal Chemistry|March 17, 1995
Amino-substituted 2-[2'-(dimethylamino)ethyl]-1,2-dihydro-3H- dibenz[de,h]isoquinoline-1,3-diones. Synthesis, antitumor activity, and quantitative structure--activity relationshipS M Sami, R T Dorr, A M Sólyom, et al.
Cancer Treatment Reports|July 1, 1985
Methotrexate: bioavailability and pharmacokineticsM A Campbell, D G Perrier, R T Dorr, et al.
Journal of Medicinal Chemistry|August 24, 2000
Analogues of amonafide and azonafide with novel ring systemsS M Sami, R T Dorr, D S Alberts, et al.
Cancer Research|January 15, 1989
Antitumor activity and murine pharmacokinetics of parenteral acronycineR T Dorr, J D Liddil, D D Von Hoff, et al.
Bone Marrow Transplantation|April 15, 2003
Comparative pharmacokinetic study of high-dose etoposide and etoposide phosphate in patients with lymphoid malignancy receiving autologous stem cell transplantationR T Dorr, A Briggs, P Kintzel, et al.
Investigational New Drugs|January 1, 1996
Antitumor activity of combretastatin-A4 phosphate, a natural product tubulin inhibitorR T Dorr, K Dvorakova, K Snead, et al.
Pageof 16